NCT07382869

Brief Summary

Gestational Diabetes Mellitus (GDM) is a growing maternal health concern associated with adverse neonatal outcomes such as macrosomia and shoulder dystocia, often aggravated by poor dietary habits and physical inactivity during pregnancy. This randomized controlled study aims to evaluate the effectiveness of structured nursing interventions focusing on diet and physical activity in improving maternal glycemic control and reducing neonatal complications. A total of 66 pregnant women diagnosed with GDM will be selected through purposive sampling and randomly allocated into intervention and control groups using the lottery method. The intervention group will receive individualized dietary counselling, pregnancy-appropriate physical activity guidance, and regular nursing follow-up, while the control group will continue with routine antenatal care. Maternal outcomes, including fasting blood glucose and HbA1c levels, will be measured at baseline and follow-up visits. Neonatal outcomes such as macrosomia, mode of delivery, and shoulder dystocia will be documented at birth. Data will be collected using structured tools and analysed using SPSS, with independent t-tests and chi-square tests applied. The study anticipates that structured nursing interventions will significantly improve glycaemic control and reduce adverse neonatal outcomes, supporting the integration of evidence-based nursing care into routine GDM management.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Mar 2026Sep 2026

First Submitted

Initial submission to the registry

December 24, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 3, 2026

Completed
26 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

6 months

First QC Date

December 24, 2025

Last Update Submit

February 8, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Maternal glycemic control assessed by HbA1c (%)

    Change in maternal glycemic control measured by glycated hemoglobin (HbA1c, %) using standardized laboratory blood assays from baseline (at enrollment) to 36-38 weeks of gestation.

    Baseline (at enrollment: 24-28 weeks gestation) to 36-38 weeks gestation

  • Fasting plasma glucose (mg/dL)

    Change in fasting plasma glucose levels (mg/dL) measured using a fasting venous blood sample at baseline and at 36-38 weeks of gestation.

    Baseline (24-28 weeks gestation) to 36-38 weeks gestation

Secondary Outcomes (5)

  • Mode of delivery

    Mode of delivery (vaginal or cesarean section) recorded from hospital obstetric records at the time of childbirth.

  • Neonatal birth weight (grams)

    Neonatal birth weight (grams) measured within the first hour after birth using a calibrated neonatal weighing scale.

  • Neonatal Apgar score

    Apgar score assessed at 1 and 5 minutes after delivery using the standard Apgar scoring system.

  • Neonatal complications

    Incidence of neonatal complications, including shoulder dystocia and neonatal hypoglycemia, assessed through standard clinical examination and review of neonatal medical records within 48 hours after birth.

  • Secondary Outcome Measure 5

    Description: Maternal weight change measured in kilograms (kg) from enrollment to delivery using routine antenatal weight records.

Study Arms (2)

Control Arm: Standard Care

NO INTERVENTION

Participants in the control group will receive standard care.

Experimental group

EXPERIMENTAL

Experimental group will receive nurse led intervention including diet,arm chair exercise and walk.

Other: Arm chair exercise, Walk, Diet plan will be given to experimental group.

Interventions

Participants in the intervention group will receive nursing intervention sessions by researcher focusing on: * Dietary modifications based on caloric needs and glycemic index education. * Safe physical activity such as walk for 150 minutes per week (30 minutes daily). * Physical exercise under supervision of nurse physical activity guidance. * To assess in the management of gestational diabetes mellitus participants will be instructed to perform simple arm raises exercise using light weights. Each session will be scheduled for 10-15 minutes and conducted three times per weeks to promote upper body strength. Studied suggest that resistant training for 20 -30 minutes a week can reduce insulin resistance. The exercise regimen will be structured to incorporate these recommendations. Participants in the active arm exercise received written step prescriptions, and set individualized targets (Diabetes Canada, 2025). * Follow-up on alternate week (15 days) and 5 counseling sessio

Experimental group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant females with indexed gestational diabetes millitus.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women aged 18-40 years
  • Diagnosed with GDM in the indexed pregnancy
  • Singleton pregnancy. Pregnant women with gravida 02.

You may not qualify if:

  • Pre-existing diabetes mellitus (Type 1 or Type 2)
  • Multiple pregnancies (twins, triplets, etc.)
  • Women with history of Pregnancy induced hypertension. (PIH)
  • History of chronic medical conditions (renal disease, cardiac disorders, epilepsy)
  • Psychiatric illness or cognitive impairment that may affect participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Of Health Sciences,Lahore.

Lahore, Punjab Province, 54000, Pakistan

Location

Related Publications (1)

  • Brown J, Ceysens G, Boulvain M. Exercise for pregnant women with pre-existing diabetes for improving maternal and fetal outcomes. Cochrane Database Syst Rev. 2017 Dec 21;12(12):CD012696. doi: 10.1002/14651858.CD012696.pub2.

    PMID: 29264871BACKGROUND

Related Links

MeSH Terms

Interventions

Walking

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Dr. Lamia Yusuf, FCPS

    Saglik Bilimleri Universitesi

    STUDY CHAIR

Central Study Contacts

Kausar Gh. Muhammad, MSN student

CONTACT

Nusrat Hussain, MSN student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Diet plan, Arm chair Exercise
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSN Student

Study Record Dates

First Submitted

December 24, 2025

First Posted

February 3, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

February 11, 2026

Record last verified: 2026-02

Locations